Exelixis (NASDAQ: EXEL) reported Q2 EPS of $0.25, $0.13 better than the analyst estimate of $0.12. Revenue for the quarter came in at $259.5 million versus the consensus estimate of $226.36 million.

GUIDANCE:

Exelixis sees FY2020 revenue of $900-950 million, versus the consensus of $908.9 million.

For earnings history and earnings-related data on Exelixis (EXEL) click here.